Venture Capital Venture Capital

Shakudo in its US$7-million financing

On February 17, 2026, Shakudo announced that it had completed a US$7-million financing round, led by Wittington Ventures. The financing will assist with the company’s expansion to the United States and launch of new products. Shakudo offers an end-to-end platform designed to help businesses...

Lead Office: Montreal Date Announced: February 17, 2026 Value: US$7 million

Modem in its closing of US$4.4-million Pre-Seed financing

On February 10, 2026, Modem announced it closed a US$4.4-million Pre-Seed financing round led by Accel, with participation from Inovia Capital and several angel investors. The company plans to utilize the funding to assist developers in shipping faster. Modem is an AI product management...

Lead Office: Toronto Date Announced: February 10, 2026 Value: US$4.4 million

Neo Financial in its $68.5-million equity financing

On February 3, 2026, Neo Financial announced that it secured $68.5 million in an oversubscribed round led by a syndicate of more than 100 Canadian founders, entrepreneurs and institutional investors, including Alberta Investment Management Corporation (AIMCo), Northleaf Capital Partners, Plaza...

Lead Office: Toronto Date Announced: February 3, 2026 Value: $68.5 million

Waabi in its US$1-billion financing

On January 28, 2026, Waabi announced that it secured US$1 billion in financing. This marks one of the largest funding rounds in Canadian tech history to date which consisted of a US$750-million Series C financing co-led by Khosla Ventures and G2 Venture Partners and an additional milestone-based...

Lead Office: Toronto Date Announced: January 28, 2026 Value: US$1 Billion

Pender Ventures in Science & Human’s $10-million Series A financing

On January 15, 2026, Science & Humans announced that it had raised $10 million of Series A financing. This amount includes $7 million in equity and $3 million in venture debt. Pender Ventures led the equity round with participation from Well Health Technologies, Michele Romanow and undisclosed...

Lead Office: Vancouver Date Announced: January 15, 2026 Value: $10 million

Genesys Capital in Enspire DBS Therapy’s $10.3-million Series B1 financing

On January 13, 2026,  Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures. Genesys Capital invests in and builds companies in the...

Lead Office: Toronto Date Announced: January 13, 2026 Value: $10.3 million

Impression Ventures in 401GO’s $33-million Series B financing

On December 9, 2025, 401GO announced it raised $33 million of Series B Financing in a round that was led by Centana Growth Partners and had participation from Impression Ventures, Next Frontier Capital and Rally Ventures. Impression Ventures is a Toronto-based venture capital firm that invests...

Lead Office: Toronto Date Announced: December 9, 2025 Value: $33 million

Clio in its US$1-billion acquisition of vLex and US$500-million Series G investment round

Osler advised Clio in its acquisition of vLex for US$1billion. This acquisition is the largest M&A transaction in the legal technology sector in history. Alongside this transaction, Clio announced a US $500-million Series G funding round at a US$5-billion valuation led by New Enterprise...

Lead Office: Vancouver Date Closed: November 10, 2025 Value: US$1billion

Wealthsimple in its $750-million Series E round at a post-money valuation of $10 billion

On October 27, 2025, Wealthsimple announced that it has signed a Series E round of up to $750 million at a post-money valuation of $10 billion. The round, which includes both a $550-million primary offering and a secondary offering of up to $200 million, is co-led by Dragoneer Investment Group and...

Lead Office: Toronto Date Announced: October 27, 2025 Value: $750 million

Felix Health in its $53-million growth financing

On October 23, 2025, Felix Health announced that it secured $53 million of growth financing from the Canadian Business Growth Fund (CBGF) and other existing investors. The capital will be used towards the growth of personalized health options for Canadians. Felix Health Inc. is a patient-driven...

Lead Office: Toronto Date Announced: October 23, 2025 Value: $53 million